Retinoic acid receptor β deletion in podocytes causes kidney and liver dysfunction, modeling nephrotic syndrome

Yuling Chi1, Krysta M DiKun1, Xiao-Han Tang1

  • 1Pharmacology Department, Weill Cornell Medicine of Cornell University, New York, New York, USA.

PubMed

Insights

Podocyte-specific deletion of retinoic acid receptor beta (Rarβ) in mice causes nephrotic syndrome and liver disease. This highlights Rarβ

Area of Science:

  • Nephrology
  • Endocrinology
  • Molecular Biology

Background:

  • Retinoic acid receptors (RARs) α, β, and γ (Rarα, β, γ) mediate all-trans retinoic acid (RA) actions.
  • Altered RAR expression is observed in nephrotic syndrome (NS) glomeruli, with reduced Rarβ.
  • Podocytes are crucial for kidney filtration and function.

Purpose of the Study:

  • To investigate the specific role of podocyte Rarβ in glomerular function.
  • To elucidate the impact of Rarβ deletion on kidney and liver physiology.
  • To establish a mouse model for studying NS and related kidney-liver crosstalk.

Main Methods:

  • Generation of a podocyte-specific Rarβ knockout mouse model (PCRB mice).
  • Analysis of kidney histology, function (albuminuria, hyperfiltration), and glomerular ultrastructure.
  • Genome-wide transcriptomics and proteomics of glomeruli and liver tissues.

Main Results:

  • Rarβ deletion in podocytes led to NS-like symptoms: podocyte loss, foot process effacement, GBM thickening, lipid accumulation, and albuminuria.
  • Increased expression of genes involved in lipid synthesis and fatty acid uptake in glomeruli.
  • Unexpectedly, podocyte-specific Rarβ deletion induced hepatic steatohepatitis and systemic hyperlipidemia.

Conclusions:

  • Podocyte Rarβ signaling is critical for maintaining kidney function and preventing NS.
  • Kidney Rarβ plays a significant role in regulating systemic lipid metabolism and liver function.
  • The PCRB mouse model effectively recapitulates key features of NS and kidney-liver crosstalk.

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
457
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
516
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
177